Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
JCO Global Oncology|April 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional StudyBhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao, et al.
Cancer|August 26, 2017
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignanciesYasmin M Abaza, Tapan M Kadia, Elias J Jabbour, et al.
Cancer Research|January 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer ImmunotherapyXue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, et al.
Molecular Cancer Therapeutics|December 29, 2012
VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancerStefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.
EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.
Nature Genetics|June 23, 2014
The genomic landscape of nasopharyngeal carcinomaDe-Chen Lin, Xuan Meng, Masaharu Hazawa, et al.
Cell Death Discovery|September 28, 2021
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancersSer Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh, et al.
International Journal of Cancer|October 11, 2017
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyValerie Heong, Nicholas L Syn, Xiao Wen Lee, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
JCO Global Oncology|April 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional StudyBhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao, et al.
Cancer|August 26, 2017
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignanciesYasmin M Abaza, Tapan M Kadia, Elias J Jabbour, et al.
Cancer Research|January 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer ImmunotherapyXue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, et al.
Molecular Cancer Therapeutics|December 29, 2012
VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancerStefan Hart, Veronica Novotny-Diermayr, Kee Chuan Goh, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.
EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.
Nature Genetics|June 23, 2014
The genomic landscape of nasopharyngeal carcinomaDe-Chen Lin, Xuan Meng, Masaharu Hazawa, et al.
Cell Death Discovery|September 28, 2021
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancersSer Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh, et al.
International Journal of Cancer|October 11, 2017
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyValerie Heong, Nicholas L Syn, Xiao Wen Lee, et al.
Pageof 25